Loading
No insider purchase over the last 90 days. The latest, by Virendra Nath Mishra, was filed 02 Jun 2026.
Insider Decl.
25
Thresholds
n/a
Buy Volume
€1M
3 ops. · all time
Sell Volume
€45M
11 ops. · all time
Who traded when
BuySaleVirendra Nath Mishra1 buy2 sales
Bhavesh Mansukhbhai Kotadiya1 buy
Chetankumar Chhaganlal Vaghasia1 sale
Mehul Mansukhbhai Koladia1 sale
Nareshkumar Ramjibhai Patel1 sale
Ram Mohan Lokhande1 sale
+1 other insider
Since the insiders bought
- +84.9%Entry ₹1,704.90 · Close 21 Oct 2026 ₹3,152.40
- +84.3%Entry ₹575.35 · Close at T+365 ₹1,060.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Acutaas Chemicals Limited Buy (bullish), based on 9 analysts. Average price target: ₹3,324.78.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 10,304 of 26,320 companies
57.0
score / 100
Value27
Quality87
FCF yld-0.1%
Earn yld1.4%
EV/EBITDA49.3x
ROE24%
Gross mgn54%
Net mgn27%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹3,151.40
Analyst consensus
9 analystsBuy
₹1,783.00Target ₹3,324.78(+6%)₹4,001.00
Income statement
Revenue₹13.3B
Gross profit₹7.1B54% margin
EBITDA₹5.2B39% margin
Net income₹3.6B26.4% margin
Valuation
PER (trailing)67.1x
PER (forward)43.0x
P/Book15.6x
Beta0.02
Balance sheet & cash
Market cap₹258B
Total debt₹356M
Free Cash Flow-₹358.1M
Debt / Equity2%
Profitability & ownership
ROE23.5%
ROA15.7%
% insiders38.3%
% institutions28.6%
Last declaration on 2 October 2026
Declarations25 total
1,000 shares@ ₹3,272.000.0012% mcap100.0% of flowEquityPledge CreationSEBI:47446db2baa4b0ebc02d90f98f818f5979f9121f
119 shares@ ₹309,053.0022.9% of flowGovernment SecurityMarket SaleSEBI:9ad1fb5cd35bce309c388b578a0ce785cbf75ff7
40,000 shares@ ₹3,090.5076.9% of flowEquity SharesMarket SaleSEBI:5eae608cc321a25c2168f352b4a9fcb994174e93
119 shares@ ₹3,145.600.2% of flowEquity SharesMarket PurchaseSEBI:25c5b2f028bcca0f43900ada12bbd34b08b1b141
Canonical exit: 31 Aug 2026 (T+90)
500 shares@ ₹2,144.262100.0% of flowEquity SharesSEBI:b4664040bb9f8cb78ea3a837bec25735e7f6a139
20,000 shares@ ₹2,110.2148.7% of flowEquity SharesSEBI:a6e9688dbc79939dabb7d59cc63b610ac8c16099
2,100 shares@ ₹1,672.34100.0% of flowEquity SharesSEBI:ab422707324c9e4452375863d0b62ae88ad278f0
Canonical exit: 29 Mar 2026 (T+90)
1,348,921 shares@ ₹1,115.0081.9% of flowEquity SharesSEBI:8870b9c01fb1ba1584826daef8ed32bcb78d0c01
1,348,921 shares@ ₹1,115.00100.0% of flowEquity SharesSEBI:517bb3156cebcf92e342cb36c1bf2d9e7128ea70
400 shares@ ₹2,130.0081.3% of flowEquity SharesSEBI:618959bd2e88e568da1b196c4994093572459e61
340,500 sharesEquity SharesSEBI:6506d55d84fe42d1609f2ec03ca47590b15819bd
340,500 sharesEquity SharesSEBI:59c9fd718f5977362b0ec09c8a09bd48b7188dac
342,000 sharesEquity SharesSEBI:a150e193a4c2aed4dd72fe75bf001176bd150072
342,000 sharesEquity SharesSEBI:b27991ff0cb6ee402210aea9dbb8e349fb7f2dae
2,937,500 sharesEquity SharesSEBI:1e1f9481ffd0d28a4807b1bc78d5d7177e7884d1
3,637,500 sharesEquity SharesSEBI:eccc1ef2cb819cffd94639cadc1822da15b70115
2,937,500 sharesEquity SharesSEBI:d3bfe80b4987862b330223632963a39d016fe896
3,637,500 sharesEquity SharesSEBI:2f882776c9dbe26cf4b0cff97f9873cf23688a88
2,000 shares@ ₹100.0018.7% of flowEquity SharesSEBI:96b468c42917284522a2578a288d879e060aed9a
25,000 shares@ ₹1,540.412451.3% of flowEquity SharesSEBI:e1cb8e45eb9dc93ec3bcf3638ef88b79876e6b9c
86,000 shares@ ₹1,163.25100.0% of flowEquity SharesSEBI:cff79fe24bfd9b7907064abc38df20c125053220
Canonical exit: 26 Mar 2024 (T+90)
274,914 shares@ ₹1,164.0018.1% of flowEquity SharesSEBI:dcfa05f305213b49b9cb47a220f7cc7139e53022
300,000 shares@ ₹1,037.25100.0% of flowEquity SharesSEBI:4d48d6adf1ef66b267893e77491162fa580aec64
300,000 shares@ ₹1,037.25100.0% of flowEquity SharesSEBI:06490ca6ff07e1a3cf063371b498b0423909f682
300,000 shares@ ₹1,037.25100.0% of flowEquity SharesSEBI:7e3f5732f9ea7739ea4962345fc3c75c41ce7c04
25 of 25 declarations
About Acutaas Chemicals Limited
Acutaas Chemicals Limited, an Indian chemicals and materials company listed in Mumbai and valued at INR 258.0 billion, has mostly seen sales by its insiders: 11 (10 with an amount) worth EUR 45.0 million, against 3 purchases worth EUR 1,127,779. The two largest sales are twins: Nareshkumar Ramjibhai Patel and Chetankumar Chhaganlal Vaghasia each sold EUR 15,670,665 on May 19, 2025. Parulben Vaghasia follows with EUR 3,913,025 on September 13, 2022.
The largest purchase, EUR 1,091,231, is by Chetankumar Chhaganlal Vaghasia on December 27, 2023; the next two are small (EUR 33,170 on December 29, 2025 by Bhavesh Mansukhbhai Kotadiya, EUR 3,378 on June 2, 2026 by Virendra Nath Mishra, Director).
Read moreShow less
The record gathers 25 filings from 14 filers, who hold 38.3% of the capital. The year 2024 holds 10 of them, against 3 in 2022 and 2 in 2023. Over the last twelve months there are 7 filings, including 2 purchases and 4 sales. The median publication delay is 1 day.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
